Skip to main content
Top
Published in: Reactions Weekly 1/2012

01-06-2012 | Case report

Thiamazole

Aplasia cutis congenita following in utero exposure: case report

Published in: Reactions Weekly | Issue 1/2012

Login to get access

Excerpt

An event is serious (FDA MedWatch definition) when the patient outcome is:
  • death
  • life-threatening
  • hospitalisation
  • disability
  • congenital anomaly
  • requires intervention to prevent permanent impairment or damage
Literature
1.
go back to reference Akar M, Dilli D, Sandal G, Erdeve O, Dilmen U.Aplasia cutis congenita due to methimazol exposure within the first trimester of pregnancy: case report. Journal of Perinatal Medicine 39: 743-4, No. 6, Nov 2011 - Turkey Akar M, Dilli D, Sandal G, Erdeve O, Dilmen U.Aplasia cutis congenita due to methimazol exposure within the first trimester of pregnancy: case report. Journal of Perinatal Medicine 39: 743-4, No. 6, Nov 2011 - Turkey
Metadata
Title
Thiamazole
Aplasia cutis congenita following in utero exposure: case report
Publication date
01-06-2012
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2012
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.2165/00128415-201214060-00123

Other articles of this Issue 1/2012

Reactions Weekly 1/2012 Go to the issue

Case report

Tetrazepam

Case report

Tacrolimus

Case report

Paromomycin